drugset / Trial / NCT06440824
A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin
RandomizedParallel-groupOpen-labelTreatment
Summary
A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-06-01
- Completion
- 2025-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Recombinant Human Thrombopoietin | Protein / enzyme biologic | 30000 iu | Subcutaneous |
| Subject | Romiplostim N01 | Peptide | 2 ug/kg | Subcutaneous |